534 related articles for article (PubMed ID: 28258701)
41. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
Leung J; Suh WK
J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
[TBL] [Abstract][Full Text] [Related]
42. B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.
Smith JB; Stashwick C; Powell DJ
Gynecol Oncol; 2014 Jul; 134(1):181-189. PubMed ID: 24657487
[TBL] [Abstract][Full Text] [Related]
43. Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines.
Sun SQ; Jiang CG; Lin Y; Jin YL; Huang PL
J Int Med Res; 2012; 40(2):497-506. PubMed ID: 22613410
[TBL] [Abstract][Full Text] [Related]
44. Host b7x promotes pulmonary metastasis of breast cancer.
Abadi YM; Jeon H; Ohaegbulam KC; Scandiuzzi L; Ghosh K; Hofmeyer KA; Lee JS; Ray A; Gravekamp C; Zang X
J Immunol; 2013 Apr; 190(7):3806-14. PubMed ID: 23455497
[TBL] [Abstract][Full Text] [Related]
45. Increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas.
Chen C; Zhu YB; Shen Y; Zhu YH; Zhang XG; Huang JA
J Immunother; 2012 May; 35(4):354-8. PubMed ID: 22495393
[TBL] [Abstract][Full Text] [Related]
46. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.
Qian Y; Hong B; Shen L; Wu Z; Yao H; Zhang L
Cell Tissue Res; 2013 Jul; 353(1):139-51. PubMed ID: 23660627
[TBL] [Abstract][Full Text] [Related]
47. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
48. Generation of avian-derived anti-B7-H4 antibodies exerts a blockade effect on the immunosuppressive response.
Lin TY; Tsai TH; Chen CT; Yang TW; Chang FL; Lo YN; Chung TS; Cheng MH; Chen WC; Tsai KC; Lee YC
Exp Anim; 2021 Aug; 70(3):333-343. PubMed ID: 33716253
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown.
Qian Y; Feng L; Wu W; Weng T; Hu C; Hong B; Wang FXC; Shen L; Wang Q; Jin X; Yao H
Cell Physiol Biochem; 2017; 44(2):494-504. PubMed ID: 29145206
[TBL] [Abstract][Full Text] [Related]
50. Changes in the subpopulation of CD25+ CD4+ and FOXP3+ regulatory T cells in decidua with respect to the progression of labor at term and the lack of analogical changes in the subpopulation of suppressive B7-H4 macrophages--a preliminary report.
Galazka K; Wicherek L; Pitynski K; Kijowski J; Zajac K; Bednarek W; Dutsch-Wicherek M; Rytlewski K; Kalinka J; Basta A; Majka M
Am J Reprod Immunol; 2009 Feb; 61(2):136-46. PubMed ID: 19143677
[TBL] [Abstract][Full Text] [Related]
51. B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer.
Liu Z; Jin K; Zeng H; Shao F; Chang Y; Wang Y; Xu L; Wang Z; Cui X; Zhu Y; Xu J
Eur J Cancer; 2022 Aug; 171():133-142. PubMed ID: 35717821
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-125b-5p modulates the inflammatory state of macrophages via targeting B7-H4.
Diao W; Lu L; Li S; Chen J; Zen K; Li L
Biochem Biophys Res Commun; 2017 Sep; 491(4):912-918. PubMed ID: 28754594
[TBL] [Abstract][Full Text] [Related]
53. B7-H1 protein vaccine induces protective and therapeutic antitumor responses in SP2/0 myeloma-bearing mice.
Zhang C; Wang W; Qin X; Xu Y; Huang T; Hao Q; Li W; Wu S; Zhang Y
Oncol Rep; 2013 Nov; 30(5):2442-8. PubMed ID: 23970300
[TBL] [Abstract][Full Text] [Related]
54. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
[TBL] [Abstract][Full Text] [Related]
55. Associations of B7-H3 and B7-H4 Expression in Ductal Carcinoma In Situ of the Breast With Clinicopathologic Features and T-Cell Infiltration.
Kim NI; Park MH; Lee JS
Appl Immunohistochem Mol Morphol; 2020; 28(10):767-775. PubMed ID: 31714284
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of B7-H4 in tumor infiltrated dendritic cells.
Cheng C; Qu QX; Shen Y; Lv YT; Zhu YB; Zhang XG; Huang JA
J Immunoassay Immunochem; 2011; 32(4):353-64. PubMed ID: 21728826
[TBL] [Abstract][Full Text] [Related]
57. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
58. Analysis of B7-H4 expression in metastatic pleural adenocarcinoma and therapeutic potential of its antagonists.
Chen C; Qu QX; Xie F; Zhu WD; Zhu YH; Huang JA
BMC Cancer; 2017 Sep; 17(1):652. PubMed ID: 28923053
[TBL] [Abstract][Full Text] [Related]
59. B7-H4 expression in various tumors determined using a novel developed monoclonal antibody.
Qian Y; Shen L; Cheng L; Wu Z; Yao H
Clin Exp Med; 2011 Sep; 11(3):163-70. PubMed ID: 21190056
[TBL] [Abstract][Full Text] [Related]
60. The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial.
John P; Wei Y; Liu W; Du M; Guan F; Zang X
Trends Pharmacol Sci; 2019 Nov; 40(11):883-896. PubMed ID: 31677920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]